Z-2298-2020 Class II Terminated
FDA device recall Z-2298-2020 was initiated by Hardy Diagnostics on Nov 14, 2019 and is designated Class II. Reason for recall: False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited. The recall status is terminated (terminated Apr 28, 2021). Affected quantity: 3,580 ea (358 kits, pack of 10 in each).
Recall details
- Product Type
- Devices
- Report Date
- Jun 17, 2020
- Initiation Date
- Nov 14, 2019
- Termination Date
- Apr 28, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,580 ea (358 kits, pack of 10 in each)
Product description
Reason for recall
Distribution pattern
U.S. Distribution in the states of WI, CA, WA, IA, MT, UT, AZ, WY, KS, MO, OR, TX, VI, including PR and Guam. OUS: British Virgin Islands, Kenya,
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2298-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hardy Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.